However, to our knowledge, no study has assessed simultaneously different parameters of subclinical atherosclerosis to demonstrate the relationship between serum GGT level and subclinical atherosclerosis in patients with TD2M, who have an increased risk of CVD [24]. The gene discussed is GGT1; the disease is atherosclerosis.